Cargando…
Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19
Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 weeks after SARS-CoV-2 infection, where elevated biomarkers of inflammation and cardiac dysfunction are the hallmark of this syn...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605437/ https://www.ncbi.nlm.nih.gov/pubmed/36295088 http://dx.doi.org/10.3390/life12101652 |
_version_ | 1784818066449760256 |
---|---|
author | Estrada-Luna, Diego Carreón-Torres, Elizabeth González-Reyes, Susana Martínez-Salazar, María Fernanda Ortiz-Rodríguez, María Araceli Ramírez-Moreno, Esther Arias-Rico, José Jiménez-Osorio, Angélica Saraí |
author_facet | Estrada-Luna, Diego Carreón-Torres, Elizabeth González-Reyes, Susana Martínez-Salazar, María Fernanda Ortiz-Rodríguez, María Araceli Ramírez-Moreno, Esther Arias-Rico, José Jiménez-Osorio, Angélica Saraí |
author_sort | Estrada-Luna, Diego |
collection | PubMed |
description | Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 weeks after SARS-CoV-2 infection, where elevated biomarkers of inflammation and cardiac dysfunction are the hallmark of this syndrome when infection or exposure to SARS-CoV-2 has been confirmed. However, after two years of acknowledgment, MIS-C treatment is still under research to reach safety and effectiveness in the acute phase in children. Therefore, in this review, we discuss the potential use of natural compounds with antioxidant and anti-inflammatory effects to reduce collateral damage caused by hyperinflammation in MIS-C pathology for new research in treatment and interventions. |
format | Online Article Text |
id | pubmed-9605437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96054372022-10-27 Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 Estrada-Luna, Diego Carreón-Torres, Elizabeth González-Reyes, Susana Martínez-Salazar, María Fernanda Ortiz-Rodríguez, María Araceli Ramírez-Moreno, Esther Arias-Rico, José Jiménez-Osorio, Angélica Saraí Life (Basel) Review Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 weeks after SARS-CoV-2 infection, where elevated biomarkers of inflammation and cardiac dysfunction are the hallmark of this syndrome when infection or exposure to SARS-CoV-2 has been confirmed. However, after two years of acknowledgment, MIS-C treatment is still under research to reach safety and effectiveness in the acute phase in children. Therefore, in this review, we discuss the potential use of natural compounds with antioxidant and anti-inflammatory effects to reduce collateral damage caused by hyperinflammation in MIS-C pathology for new research in treatment and interventions. MDPI 2022-10-20 /pmc/articles/PMC9605437/ /pubmed/36295088 http://dx.doi.org/10.3390/life12101652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Estrada-Luna, Diego Carreón-Torres, Elizabeth González-Reyes, Susana Martínez-Salazar, María Fernanda Ortiz-Rodríguez, María Araceli Ramírez-Moreno, Esther Arias-Rico, José Jiménez-Osorio, Angélica Saraí Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 |
title | Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 |
title_full | Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 |
title_fullStr | Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 |
title_full_unstemmed | Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 |
title_short | Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19 |
title_sort | nutraceuticals for complementary treatment of multisystem inflammatory syndrome in children: a perspective from their use in covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605437/ https://www.ncbi.nlm.nih.gov/pubmed/36295088 http://dx.doi.org/10.3390/life12101652 |
work_keys_str_mv | AT estradalunadiego nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT carreontorreselizabeth nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT gonzalezreyessusana nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT martinezsalazarmariafernanda nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT ortizrodriguezmariaaraceli nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT ramirezmorenoesther nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT ariasricojose nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 AT jimenezosorioangelicasarai nutraceuticalsforcomplementarytreatmentofmultisysteminflammatorysyndromeinchildrenaperspectivefromtheiruseincovid19 |